Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies

被引:91
|
作者
Benoit, DD
Hoste, EA
Depuydt, PO
Offner, FC
Lameire, NH
Vandewoude, KH
Dhondt, AW
Noens, LA
Decruyenaere, JM
机构
[1] Ghent Univ Hosp, Med Intens Care Unit, Dept Internal Med, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Intens Care Med Div, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Div Hematol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium
关键词
acute renal failure; haematological malignancy; infection; intensive care unit; renal replacement therapy;
D O I
10.1093/ndt/gfh637
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Starting renal replacement therapy (RRT) for acute renal failure in critically ill patients with haematological malignancies is controversial because of the poor outcome and high costs. The aim of this study was to compare the outcome between critically ill medical patients with and without haematological malignancies who received RRT for acute renal failure. Methods. We retrospectively collected data on all consecutive patients who received RRT for acute renal failure at the Medical Intensive Care Unit (ICU) of a University Hospital between 1997 and 2002, and assessed the impact of the presence of a haematological malignancy on the survival within 6 months after ICU admission by Cox proportional hazard models. Results. Fifty of the 222 (22.5%) consecutive patients with haematological malignancies admitted to the ICU over the study period received RRT for acute renal failure compared with 248 of the 4293 (5.8%) patients without haematological malignancies (P < 0.001). Among patients who received RRT, those with haematological malignancies had higher crude ICU (79.6 vs 55.7%, P=0.002) and in-hospital (83.7 vs 66.1%, P = 0.016) mortality rates, and a higher mortality at 6 months (86 vs 72%, P = 0.018) by Kaplan-Meier estimates compared with those without haematological malignancies. However, after adjustment for the severity of illness and the duration of hospitalization before ICU admission, haematological malignancy by itself was no longer associated with a higher risk of death (hazard ratio 1.04; 95% confidence interval, 0.73-1.54, P = 0.78). Conclusions. Medical ICU patients with haematological malignancies have a higher rate of occurrence of acute renal failure treated with RRT and a higher mortality, compared with those without haematological malignancies. However, the presence of a haematological malignancy by itself is not a reason to withhold RRT in medical ICU patients with acute renal failure.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 50 条
  • [1] Outcome in critically ill medical patients requiring renal replacement therapy for acute renal failure: comparison between patients with and without hematologic malignancies
    D Benoit
    E Hoste
    P Depuydt
    F Offner
    N Lameire
    J Decruyenaere
    K Vandewoude
    F Colardyn
    Critical Care, 8 (Suppl 1):
  • [2] Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients
    Metnitz, PGH
    Krenn, CG
    Steltzer, H
    Lang, T
    Ploder, J
    Lenz, K
    Le Gall, JR
    Druml, W
    CRITICAL CARE MEDICINE, 2002, 30 (09) : 2051 - 2058
  • [3] Medication Dosing in Critically Ill Patients With Acute Kidney Injury Treated With Renal Replacement Therapy
    Scoville, Bridget A.
    Mueller, Bruce A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (03) : 490 - 500
  • [4] Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy
    Park, J
    Gage, BF
    Vijayan, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (05) : 791 - 798
  • [5] Epidemiology of infection in critically ill patients with acute renal failure
    Reynvoet, Emmelie
    Vandijck, Dominique M.
    Blot, Stijn I.
    Dhondt, Annemieke W.
    De Waele, Jan J.
    Claus, Stefaan
    Buyle, Franky M.
    Vanholder, Raymond C.
    Hoste, Eric A. J.
    CRITICAL CARE MEDICINE, 2009, 37 (07) : 2203 - 2209
  • [6] Timing of renal replacement therapy in critically ill patients with acute kidney injury
    Bouman, Catherine S. C.
    Straaten, Heleen M. Oudemans-van
    CURRENT OPINION IN CRITICAL CARE, 2007, 13 (06) : 656 - 661
  • [7] Severe lactic acidosis in critically ill patients with acute kidney injury treated with renal replacement therapy
    De Corte, Wouter
    Vuylsteke, S.
    De Waele, Jan J.
    Dhondt, Annemieke W.
    Decruyenaere, Johan
    Vanholder, Raymond
    Hoste, Eric A. J.
    JOURNAL OF CRITICAL CARE, 2014, 29 (04) : 650 - 655
  • [8] Influence of renal replacement therapy on outcome of patients with acute renal failure
    Kresse, S
    Schlee, H
    Deuber, HJ
    Koall, W
    Osten, B
    KIDNEY INTERNATIONAL, 1999, 56 : S75 - S78
  • [9] Acute renal failure in critically ill patients
    L. Gesualdo
    G. Grandaliano
    L. Mascia
    G. Pertosa
    F. P. Schena
    Intensive Care Medicine, 1999, 25 : 1188 - 1190
  • [10] Acute renal failure in critically ill patients
    Gesualdo, L
    Grandaliano, G
    Mascia, L
    Pertosa, G
    Schena, FP
    INTENSIVE CARE MEDICINE, 1999, 25 (10) : 1188 - 1190